4 ).A significant reduction was observed in patients undergoing cardiac surgery (RR 0.39, 95% CI 0.18–0.85; P = 0.02), whereas no significant benefit was detected in non-cardiac surgical patients (RR 0.73, 95% CI 0.38–1.41; P = 0.34), although the test for subgroup differences did not reach statistical significance ( P = 0.18).
← all excerpts
Effect of dexmedetomidine on postoperative mortality and prognosis: a systematic review and meta-analysis of randomized controlled trials.
1
0.1800
0.1800